F. Vanaclocha

4.2k total citations · 1 hit paper
130 papers, 2.7k citations indexed

About

F. Vanaclocha is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, F. Vanaclocha has authored 130 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Dermatology, 47 papers in Immunology and 27 papers in Epidemiology. Recurrent topics in F. Vanaclocha's work include Psoriasis: Treatment and Pathogenesis (43 papers), Dermatology and Skin Diseases (16 papers) and Cutaneous lymphoproliferative disorders research (15 papers). F. Vanaclocha is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (43 papers), Dermatology and Skin Diseases (16 papers) and Cutaneous lymphoproliferative disorders research (15 papers). F. Vanaclocha collaborates with scholars based in Spain, United States and Germany. F. Vanaclocha's co-authors include E. Daudén, Kristian Reich, Andrew Blauvelt, Diamant Thaçi, Sophie Hugot, Andreas Pinter, Tsen‐Fang Tsai, R. You, Külli Kingo and Michael Ziv and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

F. Vanaclocha

122 papers receiving 2.6k citations

Hit Papers

Secukinumab is superior t... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
    2015 429 citations Diamant Thaçi, Andrew Blauvelt et al. Journal of the American Academy of Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F. Vanaclocha 1.7k 1.3k 460 458 377 130 2.7k
I. García‐Doval 1.2k 0.7× 1.1k 0.8× 445 1.0× 516 1.1× 586 1.6× 165 2.8k
Jeffrey Crowley 1.5k 0.9× 866 0.7× 312 0.7× 407 0.9× 244 0.6× 64 1.9k
Stefano Piaserico 1.5k 0.9× 1.6k 1.2× 295 0.6× 459 1.0× 1.2k 3.2× 158 3.7k
Siegfried Segaert 1.1k 0.6× 1.1k 0.8× 697 1.5× 227 0.5× 626 1.7× 69 3.3k
Bernard S. Goffe 2.4k 1.4× 940 0.7× 314 0.7× 1.4k 2.9× 272 0.7× 23 3.3k
Laurence Le Cleach 820 0.5× 819 0.6× 582 1.3× 503 1.1× 275 0.7× 66 2.1k
Enrique Rivas 1.4k 0.8× 763 0.6× 250 0.5× 337 0.7× 178 0.5× 13 1.7k
M. Alsina 579 0.3× 434 0.3× 234 0.5× 249 0.5× 305 0.8× 65 1.4k
Pierre‐Dominique Ghislain 685 0.4× 625 0.5× 342 0.7× 420 0.9× 215 0.6× 36 1.5k
Marcus Schmitt‐Egenolf 1.4k 0.8× 572 0.4× 102 0.2× 219 0.5× 85 0.2× 62 1.8k

Countries citing papers authored by F. Vanaclocha

Since Specialization
Citations

This map shows the geographic impact of F. Vanaclocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Vanaclocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Vanaclocha more than expected).

Fields of papers citing papers by F. Vanaclocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Vanaclocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Vanaclocha. The network helps show where F. Vanaclocha may publish in the future.

Co-authorship network of co-authors of F. Vanaclocha

This figure shows the co-authorship network connecting the top 25 collaborators of F. Vanaclocha. A scholar is included among the top collaborators of F. Vanaclocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Vanaclocha. F. Vanaclocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuño‐González, A., E. Daudén, F. Vanaclocha, et al.. (2016). Serie de casos de pacientes psoriásicas expuestas a terapia biológica durante el embarazo. Registro BIOBADADERM y revisión de la literatura. Actas Dermo-Sifiliográficas. 108(2). 168–170. 16 indexed citations
2.
Blauvelt, Andrew, Kristian Reich, Tsen‐Fang Tsai, et al.. (2016). Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study. Journal of the American Academy of Dermatology. 76(1). 60–69.e9. 231 indexed citations
3.
Vanaclocha, F., et al.. (2015). Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain. Value in Health. 18(7). A420–A420. 3 indexed citations
4.
García‐Vicuña, Rosario, Pedro Zarco, Carlos González, et al.. (2015). Incidencia a los 2 años de psoriasis, uveítis y enfermedad inflamatoria intestinal en la cohorte de pacientes con espondiloartritis del estudio AQUILES. Reumatología Clínica. 12(1). 22–26. 9 indexed citations
5.
Pujol, Ramón M., L. Puig, E. Daudén, et al.. (2013). Mental Health Self-Assessment in Patients With Moderate to Severe Psoriasis: An Observational, Multicenter Study of 1164 Patients in Spain (The VACAP Study). Actas Dermo-Sifiliográficas. 104(10). 897–903. 23 indexed citations
6.
Carretero, G., M. Ribera, I. Belinchón, et al.. (2013). Guidelines for the Use of Acitretin in Psoriasis. Actas Dermo-Sifiliográficas. 104(7). 598–616. 36 indexed citations
7.
Ramia, José Manuel, et al.. (2012). Tratamiento quirúrgico de las metástasis hepáticas de melanoma. Cirugía Española. 91(1). 4–8. 1 indexed citations
8.
Vanaclocha, F., et al.. (2011). Enfermedad de Darier segmentaria. Actas Dermo-Sifiliográficas. 102(4). 299–301. 5 indexed citations
9.
Rivera, R., I. García‐Doval, G. Carretero, et al.. (2011). BIOBADADERM: registro español de acontecimientos adversos de terapias biológicas en Dermatología. Primer informe. Actas Dermo-Sifiliográficas. 102(2). 132–141. 27 indexed citations
10.
Sanz, Jesús, et al.. (2011). Necrosis of Ears after Use of Cocaine Probably Adulterated with Levamisole. Dermatology. 223(1). 25–28. 21 indexed citations
11.
Bernengo, M.G., F. Vanaclocha, Madeleine Duvic, et al.. (2008). A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl). DIAL (Catholic University of Leuven). 93. 109. 1 indexed citations
12.
Rodríguez‐­Peralto, José Luis, et al.. (2006). Úlcera gigante en la espalda. Actas Dermo-Sifiliográficas. 97(2). 145–147. 1 indexed citations
13.
Ortiz‐Romero, Pablo L., et al.. (2006). Tratamiento de micosis fungoide con PUVA más bexaroteno. Actas Dermo-Sifiliográficas. 97(5). 311–318. 5 indexed citations
14.
Frutos, F.J. Ortiz de, et al.. (2005). Eczema alérgico de contacto profesional en auxiliar de odontología. Actas Dermo-Sifiliográficas. 96(1). 56–58. 5 indexed citations
15.
Rodríguez‐­Peralto, José Luis, et al.. (2005). Sarcoidosis subcutánea como primera manifestación de enfermedad sistémica. Actas Dermo-Sifiliográficas. 96(6). 379–381. 4 indexed citations
16.
Frutos, F.J. Ortiz de, et al.. (2005). Allergic contact dermatitis caused by 6α‐methylprednisolone aceponate. Contact Dermatitis. 53(1). 60–62. 2 indexed citations
17.
Algara, Patrocinio, Marisol Mateo, Pedro Martı́nez, et al.. (2002). p16INK4a Is Selectively Silenced in the Tumoral Progression of Mycosis Fungoides. Laboratory Investigation. 82(2). 123–132. 39 indexed citations
18.
Ho, Vincent, C.E.M. Griffiths, J. Berth‐Jones, et al.. (2001). Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study. Journal of the American Academy of Dermatology. 44(4). 643–651. 100 indexed citations
19.
Rodríguez‐­Peralto, José Luis, et al.. (1997). Cryptococcal cellulitis in an immunocompetent host. Journal of the American Academy of Dermatology. 36(1). 109–112. 9 indexed citations
20.
López‐Estebaranz, J.L., et al.. (1993). Febrile ulceronecrotic Mucha-Habermann disease. Journal of the American Academy of Dermatology. 29(5). 903–906. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. García‐Doval Breakdown of academic impact, for papers by Jeffrey Crowley Breakdown of academic impact, for papers by Stefano Piaserico Breakdown of academic impact, for papers by Siegfried Segaert Breakdown of academic impact, for papers by Bernard S. Goffe Breakdown of academic impact, for papers by Laurence Le Cleach Breakdown of academic impact, for papers by Enrique Rivas Breakdown of academic impact, for papers by M. Alsina Breakdown of academic impact, for papers by Pierre‐Dominique Ghislain Breakdown of academic impact, for papers by Marcus Schmitt‐Egenolf
Rankless by CCL
2026